Ken Fisher Tg Therapeutics, Inc. Transaction History

Fisher Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.74 - $10.66 $5.66 Million - $16.1 Million	-1,513,258 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$7.81 - $20.45 $19,876 - $52,045	-2,545 Reduced 0.17%	1,513,258 $14.4 Million
Q4 2021 Feb 02, 2022	BUY	$15.2 - $35.51 $9.63 Million - $22.5 Million	633,362 Added 71.77%	1,515,803 $28.8 Million
Q3 2021 Oct 26, 2021	BUY	$21.78 - $40.45 $9.37 Million - $17.4 Million	430,385 Added 95.21%	882,441 $29.4 Million
Q2 2021 Jul 27, 2021	BUY	$32.5 - $48.96 $14.7 Million - $22.1 Million	452,056 New	452,056 $17.5 Million
Q1 2021 Apr 27, 2021	SELL	$41.61 - $54.3 $166,440 - $217,200	-4,000 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$25.27 - $54.9 $101,080 - $219,600	4,000 New	4,000 $208,000

372

85.5M

3.78M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.14B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.